Tag: Nasdaq:AKRX

November 27, 2018

Akorn Receives Product Approval

Akorn (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, announced that it received a new Abbreviated New Drug Application (ANDA) approval...
October 29, 2018

Akorn Receives Product Approval

Akorn (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, announced that, on October 26, 2018, it received a new Abbreviated New...
October 10, 2018

Akorn Receives Product Approval

Akorn (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it has received a new Abbreviated New Drug Application...